NR0B1
Nuclear receptor subfamily 0 group B member 1
Also known as: AHC, AHCH, DAX1, DSS, NR0B1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P51843
- Gene
- NR0B1
- Ensembl
- ENSG00000169297
- Chromosome
- X
- Canonical length
- 470 aa
- Protein class
- Cancer-related genes, Disease related genes, Human disease related genes, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors
- Subcellular location
- Nuclear speckles,Vesicles,Centriolar satellite
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a protein that contains a DNA-binding domain. The encoded protein acts as a dominant-negative regulator of transcription which is mediated by the retinoic acid receptor. This protein also functions as an anti-testis gene by acting antagonistically to Sry. Mutations in this gene result in both X-linked congenital adrenal hypoplasia and hypogonadotropic hypogonadism. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
470 residues, UniProt reviewed canonical sequence.
>P51843|NR0B1
1 MAGENHQWQG SILYNMLMSA KQTRAAPEAP ETRLVDQCWG CSCGDEPGVG REGLLGGRNV
61 ALLYRCCFCG KDHPRQGSIL YSMLTSAKQT YAAPKAPEAT LGPCWGCSCG SDPGVGRAGL
121 PGGRPVALLY RCCFCGEDHP RQGSILYSLL TSSKQTHVAP AAPEARPGGA WWDRSYFAQR
181 PGGKEALPGG RATALLYRCC FCGEDHPQQG STLYCVPTST NQAQAAPEER PRAPWWDTSS
241 GALRPVALKS PQVVCEAASA GLLKTLRFVK YLPCFQVLPL DQQLVLVRNC WASLLMLELA
301 QDRLQFETVE VSEPSMLQKI LTTRRRETGG NEPLPVPTLQ HHLAPPAEAR KVPSASQVQA
361 IKCFLSKCWS LNISTKEYAY LKGTVLFNPD VPGLQCVKYI QGLQWGTQQI LSEHTRMTHQ
421 GPHDRFIELN STLFLLRFIN ANVIAELFFR PIIGTVSMDD MMLEMLCTKILocalizationUniProt · AlphaFold · HPA
Whether an antibody against NR0B1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.46
- Highest tissue expression
- 35 nTPM
Expression across tissuesHPA
Tissue
- adrenal gland: 35 nTPM
- testis: 20 nTPM
- ovary: 3.3 nTPM
- cervix: 3.1 nTPM
- pituitary gland: 2.6 nTPM
- pancreas: 2 nTPM
Single-cell type
- adrenal cortex cells: 59 nCPM
- sertoli cells: 48 nCPM
- gonadotrophs: 22 nCPM
- pancreatic islet cells: 21 nCPM
- oligodendrocyte progenitor cells: 19 nCPM
- epididymal efferent duct ciliated cells: 12 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- hypothalamus: 11 nTPM
- thalamus: 1.6 nTPM
- amygdala: 1.5 nTPM
- white matter: 1.5 nTPM
- medulla oblongata: 1.4 nTPM
- midbrain: 1.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NR0B1.
Disease | AllUniProt
Conditions NR0B1 is implicated in, by any mechanism.
- Adrenal hypoplasia, congenital (AHC) MIM:300200
- 46,XY sex reversal 2 (SRXY2) MIM:300018
Disease | GeneticClinVar
129 pathogenic / likely-pathogenic of 430 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Congenital adrenal hypoplasia, X-linked
- 46,XY sex reversal 2
- NR0B1-related disorder
- Nonpapillary renal cell carcinoma
- Differences in sex development
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.28
- gnomAD pLI
- 0.97
- gnomAD missense Z
- 1.08
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adrenal gland development
- endodermal cell differentiation
- gonad development
- hypothalamus development
- intracellular protein localization
- Leydig cell differentiation
- male gonad development
- male sex determination
- negative regulation of DNA-templated transcription
- negative regulation of gluconeogenesis
- negative regulation of intracellular steroid hormone receptor signaling pathway
- negative regulation of steroid biosynthetic process
- negative regulation of transcription by RNA polymerase II
- pituitary gland development
- response to immobilization stress
- Sertoli cell differentiation
- sex determination
- spermatogenesis
Molecular functions
- AF-2 domain binding
- nuclear receptor binding
- protein domain specific binding
- protein homodimerization activity
- RNA binding
- RNA polymerase II-specific DNA-binding transcription factor binding
- transcription corepressor activity
- DNA hairpin binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NR0B1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NR0B1 as an antibody target. Whether an autoantibody or antibody against NR0B1 could matter depends on whether native NR0B1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NR0B1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NR0B1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...